Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 293 insiders at 194 companies
- $6.3B sold by 282 insiders outside a trading plan
- $3.3B sold by 627 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Joseph F Hanna DirectorMGRCMcGrath RentCorpPlanned sale$863K 7,500 shares at $115.04 4.9% of stakeTraded Oct 1 Filed Oct 2
-
Foundation Fighting Blindness Retinal Degeneration Fund Director · +1 joint filerIRDOpus Genetics, Inc.Sale$2.8M 556,000 shares at $4.96 15% of stakeTraded Sep 30 Filed Oct 2
-
Randolph Altschuler DirectorXMTRXometry, Inc.Planned sale$1M 10,000 shares at $104.04 1.8% of stakeTraded Oct 1 Filed Oct 2
-
Francis S Soistman Jr. DirectorEHTHeHealth, Inc.Planned sale$28K 40,612 shares at $0.6900 4% of stakeTraded Oct 1–2 Filed Oct 2
-
Ita M Brennan DirectorPLPlanet Labs PBCPlanned sale$187K 11,500 shares at $16.30 4.4% of stakeTraded Oct 1 Filed Oct 2
-
Frances Arnold DirectorGOOGLAlphabet Inc., Class APlanned sale$28K 83 shares at $340.45 0.4% of stakeTraded Sep 30 Filed Oct 2
-
Gregory Baszucki DirectorRBLXRoblox CorporationPlanned sale$714K 16,666 shares at $42.87 1.3% of stakeTraded Oct 1 Filed Oct 2
-
Richard A. Heyman DirectorORICOric Pharmaceuticals, Inc.Planned sale$87K 6,700 shares at $12.91Traded Oct 1 Filed Oct 2
-
John Wendell Thompson DirectorRBRKRubrik, Inc.Planned sale$1.6M 13,500 shares at $115.69Traded Oct 1 Filed Oct 2
-
Hollings Renton DirectorANABAnaptysBio, Inc.Planned sale$249K 5,000 shares at $49.87 31% of stakeTraded Oct 1 Filed Oct 2
-
Glenn Steele Jr. MD PHD DirectorPTCTPTC Therapeutics, Inc.Planned sale$782K 12,000 shares at $65.16 35% of stakeTraded Sep 30 Filed Oct 2
-
Jeffrey Jacob Raider DirectorWRBYWarby Parker Inc.Planned sale$416K 15,000 shares at $27.70 3.4% of stakeTraded Oct 1 Filed Oct 2
-
Joseph Stilwell Director · +5 joint filersWHLRWheeler Real Estate Investment Trust, Inc.Sale$15 5 shares at $3.03 <0.1% of stakeTraded Sep 30 Filed Oct 2
-
Matthew L. Posard DirectorHALOHalozyme Therapeutics, Inc.Planned sale$568K 5,230 shares at $108.54 8.9% of stakeTraded Oct 1 Filed Oct 2
-
Daniel Freifeld DirectorMRTMarti Technologies, Inc.Sale$2.6M 1,350,000 shares at $1.91 18% of stakeTraded May 18–Sep 9 Filed Oct 2
-
Michael F Angelo DirectorVHCVirnetX Holding CorpPlanned sale$10K 1,000 shares at $10.26 3.4% of stakeTraded Sep 30 Filed Oct 2
-
Paul Cahill Sciarra DirectorJOBYJoby Aviation, Inc.Planned sale$381K 62,500 shares at $6.09 0.1% of stakeTraded Oct 2 Filed Oct 2
-
Ulrike Helfer DirectorGSLGlobal Ship Lease, Inc.Sale$179K 4,000 shares at $44.82 32% of stakeTraded Sep 30 Filed Oct 2
-
Jennifer Tejada ChairPDPagerDuty, Inc.Planned sale$1.6M 107,000 shares at $15.11 6.4% of stakeTraded Sep 30 Filed Oct 2
-
Watkin Phoebe L. Yang DirectorDOCSDoximity, Inc.Planned sale$34K 1,290 shares at $26.71 5% of stakeTraded Sep 30 Filed Oct 2
-
Sherri Goodman DirectorLTBRLightbridge CorporationPlanned sale$7,020 1,116 shares at $6.29 1.6% of stakeTraded Oct 1 Filed Oct 2
-
Thomas E Chorman DirectorSXIStandex International CorporationPlanned sale$14K 50 shares at $271.39 0.4% of stakeTraded Oct 1 Filed Oct 2
-
William S. Creekmuir DirectorFLXSFlexsteel Industries, Inc.Sale$101K 1,250 shares at $81.13 6.2% of stakeTraded Sep 14–15 Filed Oct 2
-
Martin Tuchman DirectorBPRNPrinceton Bancorp, Inc.Sale$95K 3,000 shares at $31.72 0.5% of stakeTraded Apr 3, 2023 Filed Oct 2
-
Mercedes Johnson DirectorTERTeradyne, Inc.Planned sale$67K 167 shares at $402.90 2.6% of stakeTraded Oct 1 Filed Oct 2
-
May Yihong Wu DirectorNOAHNoah Holdings Ltd.Sale$126K 16,000 shares at $7.89 44% of stakeTraded Sep 29–30 Filed Oct 2
-
Kang Jyh Lee DirectorPLABPhotronics, Inc.Sale$308K 10,000 shares at $30.75 2.9% of stakeTraded Sep 29 Filed Oct 1
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.3M 18,000 shares at $73.76 1.3% of stakeTraded Sep 29–Oct 1 Filed Oct 1
-
William Sydney Fisher DirectorGAPGap, Inc. (The)Sale$1.5M 66,344 shares at $23.06 0.4% of stakeTraded Sep 30 Filed Oct 1
-
David Brian Miller DirectorONTOOnto Innovation Inc.Planned sale$600K 2,000 shares at $300.00 16% of stakeTraded Sep 29 Filed Oct 1
-
Nicole Lamb-Hale DirectorFRTFederal Realty Investment TrustSale$163K 1,500 shares at $108.89 25% of stakeTraded Sep 30 Filed Oct 1
-
William B Gordon DirectorTTWOTake-Two Interactive Software, Inc.Planned sale$2M 10,000 shares at $202.39 18% of stakeTraded Sep 29 Filed Oct 1
-
Richard D Gebert DirectorIRTIndependence Realty Trust, Inc.Planned sale$7,235 500 shares at $14.47 1.2% of stakeTraded Oct 1 Filed Oct 1
-
Corazon (Corsee) D. Sanders DirectorLEGNLegend Biotech CorporationSale$259K 27,370 shares at $9.46 34% of stakeTraded Sep 29 Filed Oct 1
-
Ned S Holmes DirectorPBProsperity Bancshares, Inc.Planned sale$73K 1,100 shares at $66.58Traded Sep 30 Filed Oct 1
-
Margaret Knight DirectorEXODExodus Movement, Inc.Planned sale$956 135 shares at $7.08 1.1% of stakeTraded Oct 1 Filed Oct 1
-
John Wilson Boynton IV DirectorNBISNebius Group N.V.Planned sale$12K 50 shares at $235.01 <0.1% of stakeTraded Sep 29 Filed Oct 1
-
Daniel R Chard DirectorMEDMedifast Inc.Planned sale$226K 19,089 shares at $11.85 13% of stakeTraded Sep 28–29 Filed Sep 30
-
Charles D Montgomery DirectorAPTAlpha Pro Tech, Ltd.Sale$111K 21,943 shares at $5.04 47% of stakeTraded Sep 28 Filed Sep 30
-
Charles D Montgomery DirectorAPTAlpha Pro Tech, Ltd.Sale$152K 23,886 shares at $6.38 28% of stakeTraded May 11–12 Filed Sep 30
-
Donna Millar DirectorAPTAlpha Pro Tech, Ltd.Sale$35K 6,971 shares at $5.04 0.5% of stakeTraded Sep 28 Filed Sep 30
-
Xiaodong Wang DirectorONCBeOne Medicines Ltd.Planned sale$11.3M 31,028 shares at $364.79 100% of stakeTraded Sep 28 Filed Sep 30
-
Theresa Yanofsky DirectorCGCCanopy Growth CorporationSale$14K 14,920 shares at $0.9300 10% of stakeTraded Sep 28 Filed Sep 30
-
David Angelo Lazzarato DirectorCGCCanopy Growth CorporationSale$21K 22,380 shares at $0.9300 11% of stakeTraded Sep 28 Filed Sep 30
-
Joseph Bayern DirectorCGCCanopy Growth CorporationSale$2,869 3,096 shares at $0.9300 2.1% of stakeTraded Sep 28 Filed Sep 30
-
Benjamin Silbermann DirectorPINSPinterest, Inc.Planned sale$1.7M 93,750 shares at $18.53 100% of stakeTraded Sep 29–30 Filed Sep 30
-
Keith R Larson DirectorNWPXNWPX Infrastructure, Inc.Planned sale$102K 1,000 shares at $102.20 6.4% of stakeTraded Sep 28 Filed Sep 30
-
David S Marriott DirectorMARMarriott International, Inc.Sale$1.2M 3,500 shares at $352.09 1.2% of stakeTraded Sep 25 Filed Sep 29
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.